Exchange: NASDAQ·Updated 04:22 PM EDT
HRMY logo

HRMYHarmony Biosciences Holdings Inc

$36.41
$1.07
(3.03%)
Today
Closed $36.41
$0.52
(1.43%)
After Hours
EarningsAug 4
Mkt Cap$2.05B
Vol1.2M
News
all
press releases
Is HRMY Stock Worth Buying With Neutral Signals and Cheap Valuation?
Harmony Biosciences trades at discounted valuations, but investors are weighing Wakix dependence, recent earnings misses and pipeline execution.
Zacks
News Placeholder
More News
News Placeholder
Harmony Biosciences Stock Outlook as Wakix Growth Meets Pipeline
Harmony Biosciences is leveraging Wakix growth to expand its neuroscience pipeline, while advancing pitolisant programs and rare disease assets.
Zacks
News Placeholder
HRMY Growth Trends Beyond Wakix Could Shape Its Next Growth Phase
Harmony Biosciences is broadening beyond Wakix with pitolisant programs, orexin research and rare epilepsy assets to diversify growth.
Zacks
News Placeholder
Is Harmony Biosciences Holdings, Inc. (HRMY) A Good Stock To Buy Now?
Is Harmony Biosciences Holdings, Inc. (HRMY) A Good Stock To Buy Now...
Yahoo! Finance: News
News Placeholder
Harmony Biosciences Announces Poster Presentations at 2026 SLEEP Annual Meeting
Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY), today announced that six abstracts in narcolepsy and idiopathic hypersomnia have been accepted for poster presentation at SLEEP 2026, the 40th annual meeting of the Associated Professional Sleep Societies (APSS), which will be held June 14 17 in...
Business Wire
News Placeholder
Should You Buy ANI Pharmaceuticals at 9.8x Forward Earnings?
ANIP trades at 9.75x forward earnings after raising 2026 guidance, but investors must weigh Cortrophin-led growth against competition and customer concentration.
Zacks
News Placeholder
ANI Pharmaceuticals Targets Acute Gout With Cortrophin Push
ANIP expands Cortrophin into acute gout flares with a 90-person sales force as investors watch adoption, spending and 2026 milestones.
Zacks
News Placeholder
Harmony Biosciences Holdings (HRMY): One of the Best Stocks to Buy According to AI
Harmony Biosciences Holdings (HRMY): One of the Best Stocks to Buy According to AI...
Yahoo! Finance: News
News Placeholder
Harmony Biosciences to Participate in Upcoming Investor Conferences
Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY), today announced that Harmony's management team will participate in the following upcoming investor conferences. Goldman Sachs 47th Annual Global Healthcare Conference Fireside Chat: June 9, 2026, at 8:40 a.m. ET Location: Miami, FL Oppenheimer CNS...
Business Wire
News Placeholder
ANI Pharmaceuticals: Rare Disease Shift and the 2026 Playbook
ANIP leans into rare disease growth as Cortrophin and Iluvien drive specialty momentum, while 2026 focuses on retina recovery and launch cadence.
Zacks
<
1
2
...
>

Advertisement|Remove ads.